Found: 7
Select item for more details and to access through your institution.
Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis.
- Published in:
- Chronic Respiratory Disease, 2019, v. 16, n. 1, p. 1, doi. 10.1177/1479973119879678
- By:
- Publication type:
- Article
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Long-Term Immunologic Effects of Broad-Spectrum Aeroallergen Immunotherapy.
- Published in:
- International Archives of Allergy & Immunology, 2006, v. 140, n. 3, p. 245, doi. 10.1159/000093250
- By:
- Publication type:
- Article
Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 1, p. 103, doi. 10.1007/s41030-018-0056-8
- By:
- Publication type:
- Article
Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
- Published in:
- AAPS Journal, 2015, v. 17, n. 3, p. 546, doi. 10.1208/s12248-015-9733-9
- By:
- Publication type:
- Article
Changes in Neutrophil–Lymphocyte or Platelet–Lymphocyte Ratios and Their Associations with Clinical Outcomes in Idiopathic Pulmonary Fibrosis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 7, p. 1427, doi. 10.3390/jcm10071427
- By:
- Publication type:
- Article